{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:41:44Z","timestamp":1791499304914,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.spen.2010.10.008","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T04:49:42Z","timestamp":1292993382000},"page":"254-260","source":"Crossref","is-referenced-by-count":27,"title":["Pharmacotherapeutics of Tourette Syndrome and Stereotypies in Autism"],"prefix":"10.1016","volume":"17","author":[{"given":"Thilinie","family":"Rajapakse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Pringsheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2010.10.008_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1469-8749.2008.03168.x","article-title":"Understanding disability in Tourette syndrome","volume":"51","author":"Pringsheim","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2010.10.008_bib2","article-title":"American Psychiatic Association, Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"10.1016\/j.spen.2010.10.008_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nurx.2006.01.009","article-title":"Contemporary assessment of pharmacotherapy of Tourette syndrome","volume":"2","author":"Scahill","year":"2006","journal-title":"Neurorx"},{"key":"10.1016\/j.spen.2010.10.008_bib4","series-title":"Parkinson's Disease and Movement Disorders","first-page":"394","article-title":"Drug-induced movement disorders","author":"Sethi","year":"2007"},{"key":"10.1016\/j.spen.2010.10.008_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/WCO.0b013e328307bf1c","article-title":"Pediatric movement disorders: An update","volume":"21","author":"Wolf","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2010.10.008_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the U.S. Preventive Services Task Force a review of the process","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.spen.2010.10.008_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2010.10.008_bib8","first-page":"217","article-title":"Clinical global impressions, in ECDEU Assessment Manual for Psychopharmacology, Revised","author":"Guy","year":"1976"},{"key":"10.1016\/j.spen.2010.10.008_bib9","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/mds.21615","article-title":"A double blind randomized placebo control trial of levetiracetam in Tourette syndrome","volume":"22","author":"Smith-Hicks","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2010.10.008_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.pediatrneurol.2008.12.014","article-title":"Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome","volume":"40","author":"Hedderick","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2010.10.008_bib11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/01.chi.0000163279.39598.44","article-title":"A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourettes disorder","volume":"44","author":"Nicolson","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2010.10.008_bib12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1087054707306109","article-title":"Atmoxetine treatment of ADHD in children with comorbid Tourette syndrome","volume":"11","author":"Spencer","year":"2008","journal-title":"J Atten Disord"},{"key":"10.1016\/j.spen.2010.10.008_bib13","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine\u2014Reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2010.10.008_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.2009.185348","article-title":"A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome","volume":"81","author":"Jankovic","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.spen.2010.10.008_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4088\/JCP.v66n0413","article-title":"Ondansetron treatment in Tourette's disorder: A 3 week, randomized, double-blind, placebo controlled study","volume":"66","author":"Toren","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.spen.2010.10.008_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005040.pub2","article-title":"Risperidone for autism spectrum disorder","volume":"1","author":"Jesner","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.spen.2010.10.008_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10803-006-0234-7","article-title":"Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Pandina","year":"2007","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.spen.2010.10.008_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00787-007-0620-5","article-title":"Risperidone versus haloperidol in children and adolescents with AD: A randomized, controlled, double-blind trial","volume":"17","author":"Miral","year":"2008","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2010.10.008_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pnpbp.2009.09.012","article-title":"Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism","volume":"34","author":"Akhondzadeh","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.spen.2010.10.008_bib20","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder","volume":"48","author":"Marcus","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2010.10.008_bib21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2010.10.008_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.biopsych.2006.05.007","article-title":"Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study","volume":"61","author":"Amminger","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.spen.2010.10.008_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism","volume":"66","author":"King","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.spen.2010.10.008_bib24","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1097\/01.chi.0000231976.28719.2a","article-title":"Atomoxetine for hyperactivity in autism spectrum disorders: Placebo-controlled crossover pilot trial","volume":"45","author":"Arnold","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2010.10.008_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.yic.0000224787.13782.0f","article-title":"Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study","volume":"21","author":"Wasserman","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.spen.2010.10.008_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/DBP.0b013e3181739b9d","article-title":"Guanfacine in children with autism and\/or intellectual disabilities","volume":"29","author":"Handen","year":"2008","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.spen.2010.10.008_bib27","first-page":"765","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"28","author":"Correll","year":"2009","journal-title":"JAMA"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909110001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909110001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T23:26:47Z","timestamp":1544052407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909110001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1071909110001117"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2010.10.008","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}